2023-09-06 16:46:35 ET
More on Pfizer
- Seeking Alpha’s Quant Rating on Pfizer
- Historical earnings data for Pfizer
- Dividend scorecard for Pfizer
- Financial information for Pfizer
- Pfizer: The Floor To This Decline Remains To Be Seen
- Pfizer, Moderna And COVID Vaccine Patents: Implications Of Legal Cases
- Pfizer: Searching For A Bottom
- Pfizer Stock: The Right Time To Buy Now (Technical Analysis)
- FDA said to clear updated COVID shots as early as Friday
- Why is big pharma unmoved despite Medicare pricing threat?
- Pfizer, BioNTech granted EU nod for new Omicron-adapted COVID shot
- Republicans say Medicare drug negotiations will mean fewer new meds
For further details see:
Pfizer stock hits 52-week low as Moderna rolls out data on rival COVID shot